Mario Iii Candamo

Mario Candamo practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Mario Candamo's NPI, 1902460397, was assigned on May 1, 2019. Mario Candamo holds Illinois license 036170740.

Mario Candamo's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Mario Candamo's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Mario Candamo is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Mario Candamo to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mario Candamo practices. Vendor and product names are available with a free account.

Hospitalist is Mario Candamo's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Mario Candamo is licensed in Illinois.

CMS data shows 175 Medicare services from Mario Candamo across 3 procedure codes in 2024, for 94 Medicare patients. Medicare paid $18,954 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Mario Candamo in 2024. The largest group is 75 to 84, with 33 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 60% are also on Medicaid. Their average risk score is 3.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mario Candamo's median patient age at 73, with 54% women.

In 2024, Mario Candamo wrote 52 Medicare Part D claims for 19 patients. 77% of them were for generic drugs.

Mario Candamo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mario Candamo as offering telehealth.

CMS Open Payments shows 6 general payments to Mario Candamo from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $125.